Primary PTCA versus thrombolytic therapy for acute MI

Tayo Addo, Cindy L. Grines, Ellen C. Keeley

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We conducted a quantitative review of 23 trials comparing primary percutaneous transluminal coronary angioplasty (PTCA) with thrombolytic therapy for acute myocardial infarction. Our review included data on short-term and long-term outcomes, a subgroup analysis of outcomes according to the type of thrombolytic therapy used, and a comparison of results from 10 early trials with those from 13 more recent trials. We found that primary PTCA is superior to thrombolytic therapy, and there were significantly fewer major adverse cardiac events in patients treated with primary angioplasty at short-term and long-term follow-up.

Original languageEnglish (US)
Pages (from-to)12-17
Number of pages6
JournalCardiology Review
Volume20
Issue number11
StatePublished - Nov 2003

Fingerprint

Coronary Balloon Angioplasty
Thrombolytic Therapy
Angioplasty
Myocardial Infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Addo, T., Grines, C. L., & Keeley, E. C. (2003). Primary PTCA versus thrombolytic therapy for acute MI. Cardiology Review, 20(11), 12-17.

Primary PTCA versus thrombolytic therapy for acute MI. / Addo, Tayo; Grines, Cindy L.; Keeley, Ellen C.

In: Cardiology Review, Vol. 20, No. 11, 11.2003, p. 12-17.

Research output: Contribution to journalArticle

Addo, T, Grines, CL & Keeley, EC 2003, 'Primary PTCA versus thrombolytic therapy for acute MI', Cardiology Review, vol. 20, no. 11, pp. 12-17.
Addo, Tayo ; Grines, Cindy L. ; Keeley, Ellen C. / Primary PTCA versus thrombolytic therapy for acute MI. In: Cardiology Review. 2003 ; Vol. 20, No. 11. pp. 12-17.
@article{d3f8fdc3a60446308cba75b4ee850dac,
title = "Primary PTCA versus thrombolytic therapy for acute MI",
abstract = "We conducted a quantitative review of 23 trials comparing primary percutaneous transluminal coronary angioplasty (PTCA) with thrombolytic therapy for acute myocardial infarction. Our review included data on short-term and long-term outcomes, a subgroup analysis of outcomes according to the type of thrombolytic therapy used, and a comparison of results from 10 early trials with those from 13 more recent trials. We found that primary PTCA is superior to thrombolytic therapy, and there were significantly fewer major adverse cardiac events in patients treated with primary angioplasty at short-term and long-term follow-up.",
author = "Tayo Addo and Grines, {Cindy L.} and Keeley, {Ellen C.}",
year = "2003",
month = "11",
language = "English (US)",
volume = "20",
pages = "12--17",
journal = "Cardiology Board Review",
issn = "1092-6607",
publisher = "Ascend Media",
number = "11",

}

TY - JOUR

T1 - Primary PTCA versus thrombolytic therapy for acute MI

AU - Addo, Tayo

AU - Grines, Cindy L.

AU - Keeley, Ellen C.

PY - 2003/11

Y1 - 2003/11

N2 - We conducted a quantitative review of 23 trials comparing primary percutaneous transluminal coronary angioplasty (PTCA) with thrombolytic therapy for acute myocardial infarction. Our review included data on short-term and long-term outcomes, a subgroup analysis of outcomes according to the type of thrombolytic therapy used, and a comparison of results from 10 early trials with those from 13 more recent trials. We found that primary PTCA is superior to thrombolytic therapy, and there were significantly fewer major adverse cardiac events in patients treated with primary angioplasty at short-term and long-term follow-up.

AB - We conducted a quantitative review of 23 trials comparing primary percutaneous transluminal coronary angioplasty (PTCA) with thrombolytic therapy for acute myocardial infarction. Our review included data on short-term and long-term outcomes, a subgroup analysis of outcomes according to the type of thrombolytic therapy used, and a comparison of results from 10 early trials with those from 13 more recent trials. We found that primary PTCA is superior to thrombolytic therapy, and there were significantly fewer major adverse cardiac events in patients treated with primary angioplasty at short-term and long-term follow-up.

UR - http://www.scopus.com/inward/record.url?scp=0142150050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142150050&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 12

EP - 17

JO - Cardiology Board Review

JF - Cardiology Board Review

SN - 1092-6607

IS - 11

ER -